{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-005230","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.554236+00:00","generated_at":"2026-06-11T17:39:36.075594+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"The Joint Corp. Q2 system-wide sales +13% to $120.1M; financial results postponed due to review","bullets":["System-wide sales $120.1M (+13% YoY); system-wide comp sales +5%.","Clinic count 890 at June 30; subsequent openings brought total to 900 in August 2023.","Unrestricted cash $13.6M (Dec 2022: $9.7M); operating cash flow $8.4M including $4.8M ERC.","Financial results postponed due to ongoing review of regional developer arrangements (non-cash impact).","Sold 21 franchise licenses in Q2; opened 26 new clinics, closed 6."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-005230","json":"https://secwatch.observer/filing/0001171843-23-005230.json","markdown":"https://secwatch.observer/filing/0001171843-23-005230.md","text":"https://secwatch.observer/filing/0001171843-23-005230.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323005230/0001171843-23-005230-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323005230/f8k_081023.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T17:39:36.075594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1bba1bea0edc22d6f2f748d39266fd8a86ceb464","claim":"JOINT Corp reported preliminary financial results for the quarter ended June 30, 2023.","evidence_excerpt":"The Joint Corp. (the “Company”) issued a press release announcing its preliminary financial results for the quarter ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323005230/0001171843-23-005230-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}